药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dolasetron
Terbutaline
The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Nifedipine.
Dolasetron
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Nifedipine.
Dolasetron
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Nifedipine.
Dolasetron
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Nifedipine.
Dolasetron
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Nifedipine.
Dolasetron
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Nifedipine.
Dolasetron
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Nifedipine.
Dolasetron
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Nifedipine.
Dolasetron
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Nifedipine.
Dolasetron
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Nifedipine.
Dolasetron
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Nifedipine.
Dolasetron
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Nifedipine.
Dolasetron
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Nifedipine.
Dolasetron
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Nifedipine.
Dolasetron
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Nifedipine.
Dolasetron
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Nifedipine.
Dolasetron
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Nifedipine.
Dolasetron
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Nifedipine.
Dolasetron
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Nifedipine.
Dolasetron
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Nifedipine.